Sernova, Evotec Join Forces To Develop 'Functional Cure' For Diabetes
Sernova - Sernova is a regenerative medicine therapeutic technologies company creating long-term healthcare
Exciting update in Sernova's type 1 diabetes (T1D) trial | JDRF Canada
Sernova: Der nächste Meilenstein zum Geldsegen › sharedeals.de
How Sernova seeks to treat insulin-dependent diabetes
Sernova - TSX Life Sciences Investor Day - YouTube
Sernova touts first-in-human results from insulin-secreting cell implant for diabetes | Fierce Biotech
News Alert: Sernova - Developing a Functional Cure for Type I Diabetes
Sernova Phase I/II US Clinical Trial for Type-1 Diabetes Advances Following Positive Preliminary Safety and Efficacy Data | World Pharma Today
Sernova Corp. on Twitter: "@SernovaCorp Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in its Phase I/II Clinical Trial for Type-1 Diabetes https://t.co/k9sxHpDcLM #diabetes #regenerativemedicine #T1D https://t.co ...
Sernova and Evotec on Track to Initiate Clinical Testing of First iPSC-Derived Islets as a Potential Functional Cure for Type 1 Diabetes | BioInformant
Sernova in clinical development for functional cure of Type 1 Insulin-dependent diabetes - BioTuesdays
Sernova: Perfekter Partner für Diabetes-Programm von Evotec? - shareribs.com - Technology - IT und Kommunikation
Sernova - Sernova is a regenerative medicine therapeutic technologies company creating long-term healthcare
Sernova (TSX.V: SVA): Changing the Standard of Care for Type 1 Diabetes Patients - YouTube
Evotec Aktie mit Kaufempfehlung - Sernova macht Fortschritte bei Diabetes-Therapiekandidaten | 4investors
IRW-News: Sernova Corp. : Sernovas Hauptprüfer präsentiert weitere positive, vorläufige Sicherheits- und Wirksamkeitsdaten aus der laufenden klinischen Phase-I/II-Studie zur Cell Pouch bei Typ-1-Diabetes in den USA
Can Sernova and Evotec's cell therapy approach result in a functional cure for diabetes?
Sernova in clinical development for functional cure of Type 1 Insulin-dependent diabetes - BioTuesdays
Sernova meldet Durchbruch bei Typ-1-Diabetes - shareribs.com - Technology - IT und Kommunikation
Type 1 diabetes goes on trial – Eric Bender
SERNOVA Aktie :: News | Aktienkurs | CA81732W1041 | A0LBCR | FRA:PSH | ETR:PSH
Sernova Corp. on Twitter: "We are pleased to announce an exclusive global strategic partnership with @Evotec, which will enable us to advance a potential 'functional cure' for insulin-dependent #diabetes without supply constraints.
IRW-News: Sernova Corp. : Sernova gibt positive aktualisierte klinische Phase-1/2-Daten zum Cell Pouch System bei den 82. Wissenschaftlichen Sitzungen der American Diabetes Association bekannt
Sernova and Evotec collaborate to develop cell therapy for diabetes
Sernova recruits first subjects for its Cell Pouch diabetes clinical trial
